| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.0038 | 1 |